Dr Reddys Laboratories (RDY) Consolidated Net Income (2012 - 2026)

Dr Reddys Laboratories' Consolidated Net Income history runs 15 years deep, the most recent figure standing at $24.1 million for Q1 2026.

• In Q1 2026, Consolidated Net Income fell 86.84% year-over-year to $24.1 million; the TTM figure through Mar 2026 stood at $300.6 million (down 54.67% YoY), while the FY2026 annual figure was $452.0 million, down 32.64% from the prior year.
• Consolidated Net Income was $24.1 million for Q1 2026 at Dr Reddys Laboratories, down from $133.6 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $202.8 million in Q4 2023 to a low of $152.0 in Q3 2022.
• Historically, Consolidated Net Income has averaged $139.1 million across 5 years, with a median of $145.3 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Consolidated Net Income sank 100.0% in 2022, then surged 117786349.35% in 2023.
• A 5-year view of Consolidated Net Income shows it stood at $116.8 million in 2022, then soared by 73.62% to $202.8 million in 2023, then decreased by 18.03% to $166.3 million in 2024, then declined by 19.65% to $133.6 million in 2025, then tumbled by 81.94% to $24.1 million in 2026.
• The last three Consolidated Net Income figures came in at $24.1 million (Q1 2026), $133.6 million (Q4 2025), and $142.9 million (Q2 2025), per Business Quant data.